Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shervin Dashti

Neurological Surgery Louisville, KY Medical Doctor

NPI 1437294386 CMS profile 110767

210 E Gray St Ste 1105, Louisville, KY 40202

Open in the dashboard

General payments

$146,221

284 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$124,538 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Shervin Dashti of Louisville, KY is reported in the CMS Open Payments database as having received $146,221 across 284 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $124,538 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $67,795 104
2024 General $51,732 58
2023 General $9,140 26
2022 General $1,914 29
2021 General $469 14
2020 General $1,233 14
2019 General $13,937 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shervin Dashti
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Shervin Dashti were reported at $67,795. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Shervin Dashti Neurological Surgery median Middle half National median
2019 $13,937 $582 $138–$3,006 $163
2020 $1,233 $294 $76–$2,174 $114
2021 $469 $387 $105–$2,432 $132
2022 $1,914 $542 $139–$2,989 $149
2023 $9,140 $534 $145–$2,697 $160
2024 $51,732 $574 $155–$3,046 $164
2025 $67,795 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $108,779 153 payments
  2. Medical Device Business Services, Inc. $33,688 36 payments
  3. Stryker Corporation $989 22 payments
  4. DePuy Synthes Sales Inc. $846 18 payments
  5. Medtronic, Inc. $661 26 payments
  6. Medtronic USA, Inc. $439 13 payments
  7. Silk Road Medical, Inc. $156 1 payment
  8. Balt USA, LLC $142 4 payments
  9. Penumbra, Inc. $134 1 payment
  10. Boston Scientific Corporation $131 1 payment
  11. Other $256 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $86,555 48 payments
  2. Travel and Lodging $36,580 71 payments
  3. Consulting Fee $16,215 4 payments
  4. Food and Beverage $6,867 160 payments
  5. Gift $4 1 payment
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM $105,582 120 payments
  2. EMBOGUARD $15,817 6 payments
  3. Spectra $12,716 4 payments
  4. STENT Neurological Product $8,050 6 payments
  5. TRUFILL $1,282 11 payments
  6. Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device $1,246 8 payments
  7. LVIS JUNIOR $1,161 2 payments
  8. EMBOTRAP II Revascularization Device $900 1 payment
  9. Embotrap $797 6 payments
  10. STENT Neurological Product $601 3 payments
  11. Other $5,937 122 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$118,919

Medicare's payments for the services billed

Medicare patients

134

Average age 76

Services billed

503

71 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Atrial fibrillation 37%
Ischemic heart disease 36%
Diabetes 28%
Depression 28%
Heart failure 25%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

284 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record